| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00592-011-0259-Z |
| P698 | PubMed publication ID | 21293887 |
| P50 | author | Seung Jin Han | Q42871469 |
| P2093 | author name string | Dae Jung Kim | |
| Tae Ho Kim | |||
| Hae Jin Kim | |||
| Kwan Woo Lee | |||
| Yup Kang | |||
| Jong Gab Jung | |||
| Eun Suk Ha | |||
| Sung E Choi | |||
| P2860 | cites work | Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway | Q24531184 |
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance | Q29012156 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 | ||
| Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans | Q33755056 | ||
| Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. | Q34449273 | ||
| Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes | Q35677410 | ||
| Innate immunity in the liver | Q36036373 | ||
| Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects | Q36906306 | ||
| Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. | Q37216733 | ||
| A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways | Q38297619 | ||
| Interleukin-6 depletion selectively improves hepatic insulin action in obesity | Q38327645 | ||
| Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway | Q40053974 | ||
| Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase | Q40227253 | ||
| Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes | Q40266335 | ||
| Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells | Q40408658 | ||
| Interleukin-6 induces cellular insulin resistance in hepatocytes | Q40687381 | ||
| Insulin resistance and diabetes mellitus | Q41183836 | ||
| Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle | Q42135596 | ||
| Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output | Q42467904 | ||
| ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts | Q42511347 | ||
| Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects | Q42797512 | ||
| Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. | Q43439880 | ||
| Palmitate-induced apoptosis can occur through a ceramide-independent pathway | Q43559742 | ||
| Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation | Q43699235 | ||
| Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro | Q43982432 | ||
| Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice | Q44631827 | ||
| Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo | Q44816750 | ||
| How obesity causes diabetes: not a tall tale | Q45232061 | ||
| Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. | Q45877031 | ||
| Classical PKC is not associated with defective insulin signaling in patients with impaired glucose tolerance | Q46174690 | ||
| Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone | Q46620643 | ||
| Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle | Q46865480 | ||
| Role of hepatic STAT3 in brain-insulin action on hepatic glucose production | Q48596967 | ||
| Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. | Q53538930 | ||
| Increased number of islet-associated macrophages in type 2 diabetes. | Q53545508 | ||
| Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss | Q56096259 | ||
| Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance | Q56742768 | ||
| Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle | Q58449836 | ||
| P433 | issue | 2 | |
| P921 | main subject | toll-like receptor | Q408004 |
| insulin resistance | Q1053470 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 189-200 | |
| P577 | publication date | 2011-02-04 | |
| P1433 | published in | Acta Diabetologica | Q15749690 |
| P1476 | title | IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle | |
| P478 | volume | 50 |
| Q27026242 | A Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in Horses |
| Q26830077 | Adipocytes: impact on tumor growth and potential sites for therapeutic intervention |
| Q36146424 | Adiposity and immune-muscle crosstalk in South Asians &Europeans: A cross-sectional study |
| Q33849609 | Alantolactone Improves Prolonged Exposure of Interleukin-6-Induced Skeletal Muscle Inflammation Associated Glucose Intolerance and Insulin Resistance |
| Q36560528 | Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes |
| Q34361828 | Evaluation of Toll-Like receptor 2 and 4 RNA expression and the cytokine profile in postmenopausal women with metabolic syndrome |
| Q26748964 | Influence of Acute and Chronic Exercise on Glucose Uptake |
| Q39148436 | Innate immune receptors in skeletal muscle metabolism. |
| Q34297417 | Interleukin-6 deficiency causes tissue-specific changes in signaling pathways in response to high-fat diet and physical activity |
| Q60472237 | Interleukin-6 is a better metabolic biomarker than interleukin-18 in young healthy adults |
| Q64967941 | Inula L. Secondary Metabolites against Oxidative Stress-Related Human Diseases. |
| Q35929484 | Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance |
| Q36580093 | Low macrophage accumulation in skeletal muscle of obese type 2 diabetics and elderly subjects |
| Q35744922 | Mechanisms Linking Inflammation to Insulin Resistance |
| Q42359004 | Muscle cells challenged with saturated fatty acids mount an autonomous inflammatory response that activates macrophages |
| Q92683056 | Muscle function and homeostasis require cytokine inhibition of AKT activity in Drosophila |
| Q38222831 | Obesity and resistance to cancer chemotherapy: interacting roles of inflammation and metabolic dysregulation |
| Q58802831 | STAT3 in Skeletal Muscle Function and Disorders |
| Q36900212 | Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases |
| Q89890713 | Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40 |
| Q90613619 | Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders |
| Q37309992 | The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK. |
| Q38773189 | The JAK/STAT pathway in obesity and diabetes |
| Q45261661 | The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes |
| Q36028206 | The effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse |
| Q36931512 | The role of chronic inflammation in obesity-associated cancers |
| Q38140767 | The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review |
Search more.